Lataa...
Anti-TNF Withdrawal in Inflammatory Bowel Disease
The introduction of the anti-tumor necrosis factorα agents (anti-TNFα) in clinical practice has greatly advanced the treatment of inflammatory bowel disease. The use of these medications results in durable remission in a subset of patients, preventing surgery and hospitalizations. However, there are...
Tallennettuna:
| Julkaisussa: | GE Port J Gastroenterol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Karger Publishers
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5580146/ https://ncbi.nlm.nih.gov/pubmed/28868451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpge.2015.11.004 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|